Avalon Acquisition Inc. (AVAC) Adds FPA to The Beneficient Company Deal
by Marlena Haddad on 2023-06-06 at 10:15am

Avalon Acquisition Inc. (NASDAQ:AVAC) announced in an 8-K this morning that it has entered into a prepaid forward purchase agreement with RiverNorth SPAC Arbitrage Fund, the purchaser, as it works to close its combination with financial services firm The Beneficient Company, or Ben.

As part of the agreement, RiverNorth agreed to effect certain purchases of shares of Avalon Class A common stock that would have been redeemed in connection with today’s shareholder meeting to approve the business combination. The purchaser has agreed to purchase $25 million worth of Avalon Class A common stock at $10.57.

These shares will not be redeemed in connection with the meeting and will convert into shares of Class A Common Stock of Beneficient and Series A Convertible Preferred Stock of Beneficient upon consummation of the deal. The Series A Preferred Stock will convert in accordance with its terms to shares of Beneficient Class A Common Stock, and RiverNorth will hold an aggregate of 2,956,480 shares of Beneficient Class A Common Stock following the conversion.

The $25 million in proceeds will be disbursed from Avalon’s trust following the completion of its business combination with Ben. Of that, $5 million will be disbursed to Beneficient, with the remaining $20 million to be disbursed to RiverNorth to be held until the maturity date of two years following the closing of the business combination or until its earlier release per the terms of the FPA.

The FPA provides for two categories of shares: 1,064,333 shares as “purchased shares” and the remaining 1,892,147 shares as “prepaid forward shares”.

If RiverNorth has received less than $5 million in gross proceeds by the 10th anniversary of the close of the business combination, then Beneficient has agreed to issue an amount of BCH Preferred Series A-0 Units as consideration for any shortfall amounts less than $5 million from the sale of the purchased shares. The purchaser has agreed for the first six months following the transaction to not sell any shares below $5 per share or to sell more than 10% of the daily trading volume of the Beneficient Class A Common Stock if the VWAP of the Beneficient Class A Common Stock is between $5.00 and $8.00 for any such trading day.

For a period of two years following the closing of the business combination, RiverNorth may sell the prepaid forward shares at a price not lower than $10.57 per share. Upon consummation of any sales, RiverNorth must remit $10.57 per share from the reserve amount to Beneficient. At the maturity date, any remaining reserve amounts will be retained by the purchaser and any unsold prepaid forward shares will be remitted to Beneficient.

The $25 million FPA comes just hours before Avalon intends to hold its shareholder meeting to approve its business combination today at 10:00 a.m. ET.

The SPAC originally inked its $3.5 billion deal with Ben in September 2022. It is funding the transaction with $207 million from its current trust supplemented by a $383 million asset PIPE made up of ”alternative assets, valued at 100% of their most recently reported net asset value at the time of such subscription, including lending money to Variable Interest Entities to finance their acquisition of alternative assets”.

 

Recent Posts
by Kristi Marvin on 2024-10-26 at 10:00am

Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced.  That brings October’s tally to seven IPOs with one more...

by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved